3-(4-(4-methoxy-5-(pyrrolidine-1-carbonyl)thiophen-3-yl)-1H-1,2,3-triazol-1-yl)piperidine-2,6-dione

ID: ALA5076661

PubChem CID: 162641722

Max Phase: Preclinical

Molecular Formula: C17H19N5O4S

Molecular Weight: 389.44

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1c(-c2cn(C3CCC(=O)NC3=O)nn2)csc1C(=O)N1CCCC1

Standard InChI:  InChI=1S/C17H19N5O4S/c1-26-14-10(9-27-15(14)17(25)21-6-2-3-7-21)11-8-22(20-19-11)12-4-5-13(23)18-16(12)24/h8-9,12H,2-7H2,1H3,(H,18,23,24)

Standard InChI Key:  OOIINFBRWZQRRM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    6.7374  -24.3445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7374  -25.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4494  -25.5778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1615  -25.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1615  -24.3445    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4494  -23.9278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0217  -23.9340    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9355  -23.1148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1280  -22.9456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7176  -23.6613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2714  -24.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8753  -25.5830    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4494  -23.1029    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8973  -23.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3436  -23.1409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5910  -23.4787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6796  -24.2991    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4872  -24.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8752  -23.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8728  -22.2434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5120  -22.3333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8968  -21.7837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1621  -23.4831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4065  -23.1507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1479  -23.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710  -24.4788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0774  -24.3046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  7  1  0
  4 12  2  0
  6 13  2  0
 10 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 14  2  0
 16 19  1  0
 19 20  2  0
 15 21  1  0
 21 22  1  0
 19 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5076661

    ---

Associated Targets(Human)

PDE6D Tclin Protein cereblon/Phosphodiesterase 6D (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRBN Tclin Cereblon/Ikaros (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRBN Tclin Cereblon/Aiolos (164 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1A1 Tchem Cereblon/Casein kinase I alpha (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (163371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRPF1 Tchem Peregrin (2217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRIM24 Tchem Transcription intermediary factor 1-alpha (2087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 389.44Molecular Weight (Monoisotopic): 389.1158AlogP: 1.23#Rotatable Bonds: 4
Polar Surface Area: 106.42Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.56CX Basic pKa: CX LogP: 0.61CX LogD: 0.61
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -1.23

References

1. Teng M, Lu W, Donovan KA, Sun J, Krupnick NM, Nowak RP, Li YD, Sperling AS, Zhang T, Ebert BL, Fischer ES, Gray NS..  (2022)  Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.,  65  (1.0): [PMID:34965125] [10.1021/acs.jmedchem.1c01832]
2. EUbOPEN.  (2023)  EUbOPEN Chemogenomics Library - IncuCyte,  [10.6019/CHEMBL5303304]
3. EUbOPEN.  (2023)  Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library,  [10.6019/CHEMBL5308504]
4. Zimmermann, Gunther G and 8 more authors.  2014-06-26  Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site.  [PMID:24884780]
5. Cheng, Junfei; Li, Yu; Wang, Xu; Dong, Guoqiang and Sheng, Chunquan.  2020-07-23  Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer.  [PMID:32603594]